Skip to main content
PMC home page
Gut logoLink to Gut
. 1995 Feb;36(2):311–313. doi: 10.1136/gut.36.2.311

Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine.

E F Posthuma 1, R G Westendorp 1, A van der Sluys Veer 1, J C Kluin-Nelemans 1, P M Kluin 1, C B Lamers 1
PMCID: PMC1382424  PMID: 7883236

Abstract

A 19 year old man with a history of Crohn's disease treated with azathioprine and prednisone, died after a primary infection with Epstein-Barr virus. He had the characteristics of the virus associated haemophagocytic syndrome, a rare complication of viral infections, which consists of fever, constitutional symptoms, hepatosplenomegaly, liver function and coagulation abnormalities, and hypertriglyceridaemia. Additionally, there was pain, cytopenia, and histiocytic hyperplasia in the bone marrow, spleen, or lymph nodes. This severe complication has been reported previously in renal transplant patients, but not in those with inflammatory bowel disease taking azathioprine. The immunosuppressive therapy may have contributed to this fatal complication of infectious mononucleosis, and this complication should be considered when treating a patient with inflammatory bowel disease with azathioprine.

Full text

PDF
311

Images in this article

312p312-a
on p.312

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Grierson H. L., Skare J., Hawk J., Pauza M., Purtilo D. T. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease. Am J Med Genet. 1991 Sep 1;40(3):294–297. doi: 10.1002/ajmg.1320400309. [DOI] [PubMed] [Google Scholar]
  2. Hanauer S. B. Inflammatory bowel disease revisited: newer drugs. Scand J Gastroenterol Suppl. 1990;175:97–106. doi: 10.3109/00365529009093133. [DOI] [PubMed] [Google Scholar]
  3. Henter J. I., Elinder G., Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol. 1991 Feb;18(1):29–33. [PubMed] [Google Scholar]
  4. Mroczek E. C., Weisenburger D. D., Grierson H. L., Markin R., Purtilo D. T. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med. 1987 Jun;111(6):530–535. [PubMed] [Google Scholar]
  5. Penman H. G. Fatal infectious mononucleosis: a critical review. J Clin Pathol. 1970 Dec;23(9):765–771. doi: 10.1136/jcp.23.9.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Purtilo D. T., Grierson H. L., Ochs H., Skare J. Detection of X-linked lymphoproliferative disease using molecular and immunovirologic markers. Am J Med. 1989 Oct;87(4):421–424. doi: 10.1016/s0002-9343(89)80825-3. [DOI] [PubMed] [Google Scholar]
  7. Purtilo D. T. Pathogenesis and phenotypes of an X-linked recessive lymphoproliferative syndrome. Lancet. 1976 Oct 23;2(7991):882–885. doi: 10.1016/s0140-6736(76)90542-0. [DOI] [PubMed] [Google Scholar]
  8. Purtilo D. T., Strobach R. S., Okano M., Davis J. R. Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest. 1992 Jul;67(1):5–23. [PubMed] [Google Scholar]
  9. Purtilo D. T., Szymanski I., Bhawan J., Yang J. P., Hutt L. M., Boto W., DeNicola L., Maier R., Thorley-Lawson D. Epstein-Barr virus infections in the X-linked recessive lymphoproliferative syndrome. Lancet. 1978 Apr 15;1(8068):798–801. doi: 10.1016/s0140-6736(78)92999-9. [DOI] [PubMed] [Google Scholar]
  10. Reiner A. P., Spivak J. L. Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore) 1988 Nov;67(6):369–388. [PubMed] [Google Scholar]
  11. Risdall R. J., McKenna R. W., Nesbit M. E., Krivit W., Balfour H. H., Jr, Simmons R. L., Brunning R. D. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer. 1979 Sep;44(3):993–1002. doi: 10.1002/1097-0142(197909)44:3<993::aid-cncr2820440329>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  12. Sakamoto K., Freed H. J., Purtilo D. T. Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome. J Immunol. 1980 Aug;125(2):921–925. [PubMed] [Google Scholar]
  13. Straus S. E., Cohen J. I., Tosato G., Meier J. NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med. 1993 Jan 1;118(1):45–58. doi: 10.7326/0003-4819-118-1-199301010-00009. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES